$1.13 -0.03 (-2.59%)

NovaBay Pharmaceuticals, Inc. (NBY)

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative treatments for infections and skin conditions. The company is known for its research on novel antimicrobial compounds, particularly NVC-422, targeting ocular, skin, and mucous membrane infections. NovaBay aims to provide alternatives to traditional antibiotics, with a focus on anti-infective and dermatological products.

Payout Frequency

Dividend History

Pay DateAmountEx-DateRecord Date
September 29, 2025$0.802025-09-302025-09-15

Dividends Summary

Company News

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga • Benzinga Staff Writer • September 29, 2025

Multiple health care stocks experienced significant price movements during Monday's after-market trading session, with some companies seeing notable gains while others experienced declines.

Impetigo Drugs Global Strategic Business Report 2024 - Fusidane Drug Segment is Expected to Reach US$883.5 Million by 2030, with a CAGR of a 5.1%
GlobeNewswire Inc. • Researchandmarkets.Com • September 2, 2024

The global impetigo drugs market is expected to grow at a CAGR of 4.5% from 2023 to 2030, driven by factors such as the increasing incidence of impetigo, technological advancements in drug delivery, and the development of new antibiotics to combat antibiotic resistance.

NovaBay slashes prices on eyecare products for Amazon Prime Day - Investing.com
Investing.com • Investing.Com • July 16, 2024

NovaBay Pharmaceuticals is offering a 20% discount on its Avenova-branded eyecare products during Amazon Prime Day, aligning with National Dry Eye Awareness Month. The company aims to attract new and existing customers through this promotion, which comes amid growing sales of its products through online channels.

NovaBay Pharmaceuticals (NBY) Shows Fast-paced Momentum But Is Still a Bargain Stock
Zacks Investment Research • Zacks Equity Research • May 21, 2024

NovaBay Pharmaceuticals (NBY) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Looking for Undervalued Penny Stocks? Use These Tips 
PennyStocks • D. Marie • May 22, 2023

Use these tips to find undervalued penny stocks The post Looking for Undervalued Penny Stocks? Use These Tips  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.